News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhejiang Hisun Pharma Invests in US Biotech Startup


3/25/2011 1:55:28 PM

March 25, 2011 -- Zhejiang Hisun Pharma will invest $6 million in Photolitec LLC, a brand new cancer startup located in Buffalo, NY. Hisun committed to sending Photolitec $2 million immediately and $1 million each year for the next four years, plus milestones. The deal gives Hisun right of first refusal for compounds being developed in conjunction with Photolitec’s Photodynamic Therapy for oncology. More details....

Stock Symbol: (SHA: 600267)


Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES